INS and diabetes mellitus: Furthermore, FOXM1-deficient mice exhibited reduced insulin secretion, whereas the activation of FOXM1 increased β-cell replication, enhanced insulin production, and improved glucose balance, rendering FOXM1 an appealing target for the management of diabetes [111] (Figure 4).